New Boston-based healthcare investment firm ATON Partners launches

ATON Partners, a Boston-based private management advisory and investment firm focused on the healthcare sector, has opened its doors. The firm is led by Patrick Sullivan, former president and CEO of Cytyc Corp. and Daniel Levangie, former executive vice president of Cytyc Corp and co-founder of Constitution Medical.

PRESS RELEASE

BOSTON, Sept. 23, 2013 /PRNewswire/ — Patrick Sullivan and Daniel Levangie, senior executives who led the emergence of Cytyc Corporation as a leading women’s healthcare company and subsequently the formation of Constitution Medical, Inc., today announced the formation of ATON Partners, LLC. Mr. Sullivan and Mr. Levangie formed ATON Partners to provide management advisory services to early stage medical device and in vitro diagnostic companies while evaluating investment opportunities within these areas of medical technology and product development. Mr. Sullivan, former President and Chief Executive Officer of Cytyc Corporation, and Mr. Levangie, former Executive Vice President of Cytyc Corporation and President of Cytyc’s Surgical Products Division, formed Constitution Medical Investors in Partnership with Warburg Pincus Private Equity in 2008 and subsequently built Constitution Medical, Inc. Constitution Medical, Inc., developers of the Bloodhound Integrated Hematology System, was acquired by Roche Diagnostics in July 2013.
ATON Partners will provide advisory services to medical device and in vitro diagnostic companies where the principals will be able to leverage their product development, regulatory, clinical and commercial experience. Over the course of 15 years at Cytyc, one of the leading companies focused on improving healthcare for women, Sullivan and Levangie led the executive team that grew Cytyc Corporation to approximately $700 million in annual revenues while establishing operations in 20 countries.
“Both Dan and I feel fortunate to have been able to lead the team that built Cytyc Corporation to its preeminent position in women’s health, and more recently to have again led the talented CMI team as it developed the Bloodhound Integrated Hematology System. With the integration of CMI with Roche Diagnostics now complete, we are excited to put our extensive experience to work in a new venture,” said Mr. Sullivan. “We are proud of our track record of success in creating value in the healthcare marketplace, and are looking forward to working with other talented management teams to provide guidance based upon our combined 50 years of experience in building great companies and significant shareholder value.”
About ATON Partners, LLC
ATON Partners, LLC is a Boston-based private management advisory and investment firm focused on healthcare sector-related companies and technologies, led by Patrick Sullivan, formerly President and Chief Executive Officer of Cytyc Corporation and and Daniel Levangie, formerly Executive Vice President of Cytyc Corporation and President of Cytyc’s Surgical Products Division. ATON Partners focuses exclusively on companies involved in the development and commercialization of medical devices and in vitro diagnostics as well as investments in innovative, healthcare-related platform technologies and companies where the principals will be able to leverage their product development, regulatory, clinical and commercial experience. For more information, visit www.ATONPartners.com ATON Partners, LLC is located at 75 Arlington Street, Suite 500, Boston, MA 02116.